These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27655680)

  • 1. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.
    Parry HM; Stevens T; Oldreive C; Zadran B; McSkeane T; Rudzki Z; Paneesha S; Chadwick C; Stankovic T; Pratt G; Zuo J; Moss P
    Oncotarget; 2016 Oct; 7(42):68513-68526. PubMed ID: 27655680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha.
    Katrinakis G; Kyriakou D; Papadaki H; Kalokyri I; Markidou F; Eliopoulos GD
    Acta Haematol; 1996; 96(1):16-23. PubMed ID: 8677756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
    Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
    Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
    Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
    Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
    Huergo-Zapico L; Acebes-Huerta A; Gonzalez-Rodriguez AP; Contesti J; Gonzalez-García E; Payer AR; Villa-Alvarez M; Fernández-Guizán A; López-Soto A; Gonzalez S
    PLoS One; 2014; 9(10):e108326. PubMed ID: 25286418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.
    Veuillen C; Aurran-Schleinitz T; Castellano R; Rey J; Mallet F; Orlanducci F; Pouyet L; Just-Landi S; Coso D; Ivanov V; Carcopino X; Bouabdallah R; Collette Y; Fauriat C; Olive D
    J Clin Immunol; 2012 Jun; 32(3):632-46. PubMed ID: 22318393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Zou YX; Zhu HY; Li XT; Xia Y; Miao KR; Zhao SS; Wu YJ; Wang L; Xu W; Li JY
    Hematol Oncol; 2019 Oct; 37(4):392-400. PubMed ID: 31420873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features.
    Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
    Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
    Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C
    Front Immunol; 2021; 12():619069. PubMed ID: 34108958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.
    Hoeller S; Zhou Y; Kanagal-Shamanna R; Xu-Monette ZY; Hoehn D; Bihl M; Swerdlow SH; Rosenwald A; Ott G; Said J; Dunphy CH; Bueso-Ramos CE; Lin P; Wang M; Miranda RN; Tzankov A; Medeiros LJ; Young KH
    Hum Pathol; 2013 Jan; 44(1):110-21. PubMed ID: 22944294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
    Kroft SH; Dawson DB; McKenna RW
    Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia.
    Villa-Álvarez M; Sordo-Bahamonde C; Lorenzo-Herrero S; Gonzalez-Rodriguez AP; Payer AR; Gonzalez-Garcia E; Villa-Álvarez MC; López-Soto A; Gonzalez S
    Front Immunol; 2018; 9():2917. PubMed ID: 30619281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.
    Reiners KS; Topolar D; Henke A; Simhadri VR; Kessler J; Sauer M; Bessler M; Hansen HP; Tawadros S; Herling M; Krönke M; Hallek M; Pogge von Strandmann E
    Blood; 2013 May; 121(18):3658-65. PubMed ID: 23509156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.
    MacFarlane AW; Jillab M; Smith MR; Alpaugh RK; Cole ME; Litwin S; Millenson MM; Al-Saleem T; Cohen AD; Campbell KS
    Oncoimmunology; 2017; 6(7):e1330235. PubMed ID: 28811973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.